Thalidomide reduced inflammatory stimulation, including the production of TNF indirectly, and interfered with the transcriptional regulation of NF‐κB in ECs directly for the simultaneous inhibition of glioma angiogenesis (Table 1). The gene discussed is TNF; the disease is glioma.